Konopka, Malchersp. j.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2019-08-14
Registered address
ul. Armii Krajowej 13, 74-400 Dębno, Poland

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 2 of 5 financial statements were filed late (the longest delay 53 days for 2021).

  • 2025not filed
  • 202412/08/2025
  • 202328/06/2024
  • 202229/03/2023
  • 202106/09/2022
  • 202016/09/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue
This companyUSD 4.02mMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD 141.62kMedianUSD 20.66kAverageUSD 86.55k
Operating costs
This companyUSD 3.86mMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 797.12kMedianUSD 544.32kAverageUSD 1.76m

National Health Fund (NFZ) contracts

Konopka, Malcher has been an NFZ healthcare provider since 2024. In 2026 it is performing 5 contracts with a total value of USD 837.39. All its contracts were worth USD 1.26k in total.

NFZ contract value by year (USD)

Type of careNFZ branchContractsValue in 2026
Pilot programmeszachodniopomorskie2USD 756.35
Pilot programmeswielkopolskie1USD 81.04
Other services provided in pharmacieszachodniopomorskie2USD 0.00

Authorized Representatives

Dominik Michał Zdziech – Attorney-in-fact (sole)

Manner of representation

Each partner is entitled to represent the company. Each partner is authorized independently to make declarations of will and sign on behalf of the company.

Ownership

Owner
Aneta Weronika Konopkaage 39
Jacek Maria Malcherage 43
Dominik Michał Zdziech

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2019-10-01.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

4 public aid cases recorded, with a total value of $35,777.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$2,517
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$2,870
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$2,696

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Modrzewscysp. j.
Ms-Pharmsp. z o.o. + limited partnership
Farmjug Agsp. z o.o.
MagmaxS.A.
Adpharmasp. z o.o.
Alfa Pharm - Małgorzata Janusik, Jarosław Janusiksp. j.
Novopharm - Millersp. j.
Pikadasp. z o.o.
Eurekasp. z o.o.
Przedsiębiorstwo Zaopatrzenia Farmaceutycznego Cefarm-SzczecinS.A.

Change history

DateEvent
2020-06-24PKD change
2019-08-14Entered in the register

FAQ

Last updated: 2026-03-30